India looks to Italy as way to move away from Chinese APIs; China expects its domestic industry to grow;

> India is looking to API producers in Italy to reduce its reliance on Chinese companies. Report

> Dalton Pharma Services says Health Canada has found its API manufacturing operations "compliant" with its new guidance. Release

> A new report from CPhI says Chinese drugmakers, on average, expect to see their sales double in the next 5 years, as the cost advantages for API making in the country continue to play out. Report

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.